RT @ElizSMcKenna: At the #ASCO23 #BreastCancer Clinical Science Symposium? ICYMI in @CD_AACR: Genomic & Transcriptomic Analyses of Breast C…
RT @ElizSMcKenna: At the #ASCO23 #BreastCancer Clinical Science Symposium? ICYMI in @CD_AACR: Genomic & Transcriptomic Analyses of Breast C…
RT @aftimosp: You can learn more on AURORA 👇
RT @ElizSMcKenna: At the #ASCO23 #BreastCancer Clinical Science Symposium? ICYMI in @CD_AACR: Genomic & Transcriptomic Analyses of Breast C…
RT @ElizSMcKenna: At the #ASCO23 #BreastCancer Clinical Science Symposium? ICYMI in @CD_AACR: Genomic & Transcriptomic Analyses of Breast C…
RT @aftimosp: You can learn more on AURORA 👇
RT @aftimosp: You can learn more on AURORA 👇
You can learn more on AURORA 👇
RT @ElizSMcKenna: At the #ASCO23 #BreastCancer Clinical Science Symposium? ICYMI in @CD_AACR: Genomic & Transcriptomic Analyses of Breast C…
At the #ASCO23 #BreastCancer Clinical Science Symposium? ICYMI in @CD_AACR: Genomic & Transcriptomic Analyses of Breast Cancer Primaries & Matched Metastases in AURORA, the @BIGagainstBC Molecular Screening Initiative - by @aftimosp Martine Piccart
RT @aftimosp: @lab_kok @prat_aleix @ChristineDesme2 @PTarantinoMD Hi Marleen , this is what we found in the first analyses in AURORA http…
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative | Cancer Discovery | American Association for Cancer Research #breastcancer #genetics https
Many many thanks Philippe! As expected but important to have these data!
@lab_kok @prat_aleix @ChristineDesme2 @PTarantinoMD Hi Marleen , this is what we found in the first analyses in AURORA https://t.co/ZyaAUEuwc4 https://t.co/4I5fA3SRq9
RT @aftimosp: In the first analyses from the AURORA molecular screening program, we found that up to 51% of patients with MBC had a least 1…
RT @aftimosp: In the first analyses from the AURORA molecular screening program, we found that up to 51% of patients with MBC had a least 1…
RT @aftimosp: In the first analyses from the AURORA molecular screening program, we found that up to 51% of patients with MBC had a least 1…
In the first analyses from the AURORA molecular screening program, we found that up to 51% of patients with MBC had a least 1 tier I or tier II alteration as per @myESMO ESCAT https://t.co/ZyaAUEtYmw #ASCO22 #bcsm #PrecisionMedicine https://t.co/gKYbV9
RT @ElizSMcKenna: ICYMI in @CD_AACR: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the B…
RT @ElizSMcKenna: ICYMI in @CD_AACR: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the B…
RT @ElizSMcKenna: ICYMI in @CD_AACR: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the B…
RT @ElizSMcKenna: ICYMI in @CD_AACR: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the B…
RT @ElizSMcKenna: ICYMI in @CD_AACR: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the B…
RT @aftimosp: We demonstrated in the @BIGagainstBC AURORA molecular screening study that 51% of patients with MBC had tumors harbouring at…
RT @ElizSMcKenna: ICYMI in @CD_AACR: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the B…
RT @aftimosp: We demonstrated in the @BIGagainstBC AURORA molecular screening study that 51% of patients with MBC had tumors harbouring at…
ICYMI in @CD_AACR: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the Breast International Group molecular screening initiative @aftimosp @MOliveira_MD @BIGagainstBC @JulesBordet @ULBruxelles #SABCS21 https
RT @aftimosp: We demonstrated in the @BIGagainstBC AURORA molecular screening study that 51% of patients with MBC had tumors harbouring at…
RT @aftimosp: We demonstrated in the @BIGagainstBC AURORA molecular screening study that 51% of patients with MBC had tumors harbouring at…
RT @aftimosp: We demonstrated in the @BIGagainstBC AURORA molecular screening study that 51% of patients with MBC had tumors harbouring at…
RT @aftimosp: We demonstrated in the @BIGagainstBC AURORA molecular screening study that 51% of patients with MBC had tumors harbouring at…
We demonstrated in the @BIGagainstBC AURORA molecular screening study that 51% of patients with MBC had tumors harbouring at least 1 Tier I/II ESCAT alteration (36% if we exclude HER2 amplification) https://t.co/7NlMjFXGom #SABCS21 #bcsm https://t.co/NuZuw
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @StoverLab: Breast cancer primary:metasasis tissue pairs are challenging to identify - but so valuable as we try to understand how #brea…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @StoverLab: Breast cancer primary:metasasis tissue pairs are challenging to identify - but so valuable as we try to understand how #brea…
RT @StoverLab: Breast cancer primary:metasasis tissue pairs are challenging to identify - but so valuable as we try to understand how #brea…
RT @StoverLab: Breast cancer primary:metasasis tissue pairs are challenging to identify - but so valuable as we try to understand how #brea…
Breast cancer primary:metasasis tissue pairs are challenging to identify - but so valuable as we try to understand how #breastcancer evolves. Congrats to @aftimosp & the @BIGagainstBC team - important data from AURORA.
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @aftimosp: 🙏🙏🙏 @BCRFcure @BIGagainstBC @MOliveira000
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
AURORA ⭐️
RT @aftimosp: 🙏🙏🙏 @BCRFcure @BIGagainstBC @MOliveira000
RT @aftimosp: 🙏🙏🙏 @BCRFcure @BIGagainstBC @MOliveira000
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @DebFumagalli: Proud to have contributed to this initiative with many colleagues, investigators and Groups from the @BIGagainstBC networ…
RT @DebFumagalli: Proud to have contributed to this initiative with many colleagues, investigators and Groups from the @BIGagainstBC networ…
RT @aftimosp: 🙏🙏🙏 @BCRFcure @BIGagainstBC @MOliveira000
RT @aftimosp: 🙏🙏🙏 @BCRFcure @BIGagainstBC @MOliveira000
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @aftimosp: 🙏🙏🙏 @BCRFcure @BIGagainstBC @MOliveira000
RT @aftimosp: 🙏🙏🙏 @BCRFcure @BIGagainstBC @MOliveira000
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
RT @aftimosp: 🙏🙏🙏 @BCRFcure @BIGagainstBC @MOliveira000
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA. Open access. By Philippe Aftimos @aftimosp https://t.co/CqVt8WY94u
RT @DebFumagalli: Proud to have contributed to this initiative with many colleagues, investigators and Groups from the @BIGagainstBC networ…
Proud to have contributed to this initiative with many colleagues, investigators and Groups from the @BIGagainstBC network. AURORA was made possible thanks to the support of @BCRFcure and the generosity of more than 1000 patients with #metastaticbreastcanc
RT @aftimosp: 🙏🙏🙏 @BCRFcure @BIGagainstBC @MOliveira000
🙏🙏🙏 @BCRFcure @BIGagainstBC @MOliveira000
RT @CD_AACR: From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the…
From the November issue: Genomic and transcriptomic analyses of #breastcancer primaries and matched metastases in AURORA, the Breast International Group molecular screening initiative. https://t.co/Cy6ka2GVgk @aftimosp @BIGagainstBC @JulesBordet @ULBruxell
RT @BenWestphalen: Congratulations to our great @OncoAlert 🚨 and @myESMO superstar @aftimosp on his most recent @CD_AACR paper originating…
RT @BenWestphalen: Congratulations to our great @OncoAlert 🚨 and @myESMO superstar @aftimosp on his most recent @CD_AACR paper originating…
RT @BenWestphalen: Congratulations to our great @OncoAlert 🚨 and @myESMO superstar @aftimosp on his most recent @CD_AACR paper originating…
Congratulations to our great @OncoAlert 🚨 and @myESMO superstar @aftimosp on his most recent @CD_AACR paper originating from the #bcsm AURORA trial. https://t.co/oOoKXVtoHB https://t.co/8VjvqN3RkX
We used @myESMO ESCAT to rank the molecular alterations reported on a sample-by-sample basis to the investigators (and treating physicians) in the @BIGagainstBC AURORA molecular screening 🧬🎯 https://t.co/ki4kDu1Y3r @MOliveira000 #bcsm #PrecisionMedicine ht
RT @prat_aleix: 10/16 -- Where does metastatic HER2-E disease come from? here combined data from 3 studies, including AURORA data @aftimosp…
RT @prat_aleix: 10/16 -- Where does metastatic HER2-E disease come from? here combined data from 3 studies, including AURORA data @aftimosp…
RT @prat_aleix: 10/16 -- Where does metastatic HER2-E disease come from? here combined data from 3 studies, including AURORA data @aftimosp…
RT @prat_aleix: 10/16 -- Where does metastatic HER2-E disease come from? here combined data from 3 studies, including AURORA data @aftimosp…
RT @prat_aleix: 10/16 -- Where does metastatic HER2-E disease come from? here combined data from 3 studies, including AURORA data @aftimosp…
10/16 -- Where does metastatic HER2-E disease come from? here combined data from 3 studies, including AURORA data @aftimosp @MOliveira000 @BIGagainstBC 50% of HER2E come from primary LumA and B tumors! subtype switching is real! https://t.co/R0vOToXBDA h
RT @aftimosp: 1/16 Important milestone today with the publication in @CD_AACR of the first manuscript from the @BIGagainstBC AURORA molecul…
IBBL contributes to the first results of #European study #AURORA, advancing the understanding of the molecular changes driving #metastatic #breastcancer @BIGagainstBC @JulesBordet Read the news: https://t.co/E49telUpHH Read the scientific publication: htt
Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative https://t.co/bJdE5lGqeV #hvhebron #onco [Text complet] @CD_AACR
RT @prat_aleix: very happy to see that our findings published in @CR_AACR in 2017 by @CejalvoM regarding "subtype switching" with 123 paire…
RT @prat_aleix: very happy to see that our findings published in @CR_AACR in 2017 by @CejalvoM regarding "subtype switching" with 123 paire…
RT @MichaelGnant: Opening the door for the future of oncology…. Congratulations! Genomic and transcriptomic analyses of breast cancer prim…
Opening the door for the future of oncology…. Congratulations! Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative https://t.co/6ATC1yfAyh